Literature DB >> 28842123

MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma.

Xiuyu Wang1, Shupeng Sun2, Xiaoguang Tong3, Quanfeng Ma4, Hui Di5, Tao Fu6, Zhen Sun7, Ying Cai8, Weijia Fan9, Qiaoli Wu10, Yidi Li11, Qiong Wang12, Jinhuan Wang13.   

Abstract

MicroRNAs (miRNAs) play a critical role in glioblastoma initiation and progression. PIWIL1, a human homolog of the PIWI family, has a critical effect on glioblastoma progression. In present study, we found that the expression of miR-154-5p was significantly lower in glioblastoma. Our results suggested that the overexpression of miR-154-5p suppressed proliferation and metastasis, induced apoptosis, whereas inhibiting the expression of miR-154-5p significantly promoted proliferation and metastasis of glioblastoma. We further proved that miR-154-5p directly integrated with the 3'-UTR of PIWIL1 and reintroduction of PIWIL1 can rescue the phenotype changes induced by miR-154-5p. Taken together, our study reveals that miR-154-5p can counteract the malignant phenotypes of glioblastoma by targeting PIWIL1, which might be beneficial to reveal new therapeutic targets for glioblastoma.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Glioblastoma; Metastasis; PIWIL1; Proliferation; miR-154-5p

Mesh:

Substances:

Year:  2017        PMID: 28842123     DOI: 10.1016/j.brainres.2017.08.014

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma.

Authors:  C Shu; Q Wang; X Yan; J Wang
Journal:  Clin Transl Oncol       Date:  2018-04-27       Impact factor: 3.405

2.  PIWI-like protein 1 upregulation promotes gastric cancer invasion and metastasis.

Authors:  Chun-Li Gao; Rui Sun; Dong-Hai Li; Fei Gong
Journal:  Onco Targets Ther       Date:  2018-12-06       Impact factor: 4.147

3.  SNHG1 promotes malignant biological behaviors of glioma cells via microRNA-154-5p/miR-376b-3p- FOXP2- KDM5B participating positive feedback loop.

Authors:  Han Li; Yixue Xue; Jun Ma; Lianqi Shao; Di Wang; Jian Zheng; Xiaobai Liu; Chunqing Yang; Qianru He; Xuelei Ruan; Zhen Li; Yunhui Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-02-06

4.  miR-154-5p Functions as an Important Regulator of Angiotensin II-Mediated Heart Remodeling.

Authors:  Que Wang; Xiaoxue Yu; Lin Dou; Xiuqing Huang; Kaiyi Zhu; Jun Guo; Mingjing Yan; Siming Wang; Yong Man; Weiqing Tang; Tao Shen; Jian Li
Journal:  Oxid Med Cell Longev       Date:  2019-09-12       Impact factor: 6.543

5.  MicroRNA-181 inhibits glioblastoma cell growth by directly targeting CCL8.

Authors:  Fengyu Zhai; Xinfeng Chen; Qianyi He; Heng Zhang; Yongqiang Hu; Dan Wang; Shasha Liu; Yi Zhang
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

6.  The Prognosis Value of PIWIL1 and PIWIL2 Expression in Pancreatic Cancer.

Authors:  Weiyao Li; Javier Martinez-Useros; Nuria Garcia-Carbonero; Maria J Fernandez-Aceñero; Luis Ortega-Medina; Sandra Garcia-Botella; Elia Perez-Aguirre; Luis Diez-Valladares; Jesus Garcia-Foncillas
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

7.  LncRNA MALAT1 promotes neuropathic pain progression through the miR‑154‑5p/AQP9 axis in CCI rat models.

Authors:  Jianping Wu; Chuanguang Wang; Haiyang Ding
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

Review 8.  PIWI proteins and piRNAs in cervical cancer: a propitious dart in cancer stem cell-targeted therapy.

Authors:  Midhunaraj Kunnummal; Mary Angelin; Ani V Das
Journal:  Hum Cell       Date:  2021-08-09       Impact factor: 4.374

9.  MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway.

Authors:  Liwei Ruan; Xiaojun Qian
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.976

10.  lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.

Authors:  Kai Chen; Zhuqing Zhang; Aijun Yu; Jian Li; Jinlong Liu; Xuejun Zhang
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.